MRI in multiple sclerosis: What’s inside the toolbox?

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Neurotherapeutics

• Publication date

  2007-10-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.nurt.2007.08.001PMID 17920541PMCID PMC7479680
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cerebral cortical lesions in multiple sclerosis detected by MR imaging at 8 Tesla.

  2007influential reference
• Double inversion recovery brain imaging at 3T: diagnostic value in the detection of multiple sclerosis lesions.

  2007influential reference
• Iron in chronic brain disorders: Imaging and neurotherapeutic implications

  2007cited by this paper
• Thalamic atrophy and cognition in multiple sclerosis

  2007cited by this paper
• Magnetic resonance imaging of myelin

  2007cited by this paper
• Magnetization transfer magnetic resonance imaging of the brain, spinal cord, and optic nerve

  2007influential reference
• Quantitative diffusion weighted imaging measures in patients with multiple sclerosis

  2007cited by this paper
• Diffusion tensor imaging of post mortem multiple sclerosis brain

  2007cited by this paper
• I nterferon beta-1a slows progression of brain atrophy in relapsing-remitting multiple sclerosis predominantly by reducing gray matter atrophy

  2007cited by this paper
• Time-series modeling of multiple sclerosis disease activity: A promising window on disease progression and repair potential?

  2007cited by this paper
• Deep grey matter `black T2` on 3 tesla magnetic resonance imaging correlates with disability in multiple sclerosis

  2007cited by this paper
• Diffusion tensor MR imaging of the cervical spinal cord in patients with multiple sclerosis

  2007cited by this paper
• The long-term effect of AHSCT on MRI measures of MS evolution: a five-year follow-up study

  2007cited by this paper
• Axonal Damage But No Increased Glial Cell Activity in the Normal-Appearing White Matter of Patients with Clinically Isolated Syndromes Suggestive of Multiple Sclerosis Using High-Field Magnetic Resonance Spectroscopy

  2007cited by this paper
• Biologic Effects of 3 Tesla (T) MR Imaging Comparing Traditional 1.5 T and 0.6 T in 1023 Consecutive Outpatients

  2007cited by this paper
• Correlation of diffusion tensor and dynamic perfusion MR imaging metrics in normal-appearing corpus callosum: support for primary hypoperfusion in multiple sclerosis.

  2007cited by this paper
• Quantitative proton magnetic resonance spectroscopy of the human cervical spinal cord at 3 tesla

  2007cited by this paper
• Optic Nerve Imaging in Multiple Sclerosis

  2007cited by this paper
• Quantification of subtle blood-brain barrier disruption in non-enhancing lesions in multiple sclerosis: a study of disease and lesion subtypes

  2007cited by this paper
• Diffusion tensor imaging of the brain

  2007cited by this paper
• Examination of spinal cord tissue architecture with magnetic resonance diffusion tensor imaging

  2007cited by this paper
• Conventional MRI in Multiple Sclerosis

  2007cited by this paper
• Reproducibility of three whole-brain N-acetylaspartate decline cohorts in relapsing-remitting multiple sclerosis.

  2007cited by this paper
• Multislice Brain Myelin Water Fractions at 3T in Multiple Sclerosis

  2007cited by this paper
• In vivo assessment of cervical cord damage in MS patients: a longitudinal diffusion tensor MRI study.

  2007cited by this paper
• Normal-appearing grey and white matter T1 abnormality in early relapsing–remitting multiple sclerosis: a longitudinal study

  2007cited by this paper
• Predicting short-term disability in multiple sclerosis

  2007cited by this paper
• Segmentation of gadolinium‐enhanced lesions on MRI in multiple sclerosis

  2007cited by this paper
• Normal-appearing white and grey matter damage in MS

  2007cited by this paper
• Imaging correlates of axonal swelling in chronic multiple sclerosis brains

  2007cited by this paper
• Multiple sclerosis: hyperintense lesions in the brain on nonenhanced T1-weighted MR images evidenced as areas of T1 shortening.

  2007cited by this paper
• Relationship of triple dose contrast enhanced lesions with clinical measures and brain atrophy in early relapsing-remitting multiple sclerosis: a two-year longitudinal study

  2007cited by this paper
• Magnetisation transfer ratio in the normal appearing white matter predicts progression of disability over 1 year in early primary progressive multiple sclerosis

  2007cited by this paper
• T1‐ and T2‐Based MRI Measures of Diffuse Gray Matter and White Matter Damage in Patients with Multiple Sclerosis

  2007cited by this paper
• Structure of WM bundles constituting the working memory system in early multiple sclerosis: A quantitative DTI tractography study

  2007cited by this paper
• Voxel-based analysis of grey matter magnetization transfer ratio maps in early relapsing remitting multiple sclerosis

  2007cited by this paper
• Determinants of cerebral atrophy rate at the time of diagnosis of multiple sclerosis.

  2007cited by this paper
• MR Spectroscopy in Multiple Sclerosis

  2007cited by this paper
• Onset and underpinnings of white matter atrophy at the very early stage of multiple sclerosis - a two-year longitudinal MRI/MRSI study of corpus callosum

  2007cited by this paper
• Magnetic resonance imaging of human brain macrophage infiltration

  2007cited by this paper
• Discordant white matter N-acetylasparate and diffusion MRI measures suggest that chronic metabolic dysfunction contributes to axonal pathology in multiple sclerosis

  2007cited by this paper
• Gray matter involvement in multiple sclerosis

  2007cited by this paper
• Positron emission tomography imaging of neuroinflammation

  2007cited by this paper
• Voxel-based analysis of the evolution of magnetization transfer ratio to quantify remyelination and demyelination with histopathological validation in a multiple sclerosis lesion

  2007cited by this paper
• Testosterone treatment in multiple sclerosis: a pilot study.

  2007cited by this paper
• Recent advances in magnetic resonance neurospectroscopy

  2007cited by this paper
• MRI outcomes in a placebo-controlled trial of natalizumab in relapsing MS

  2007cited by this paper
• Deep gray matter and fatigue in MS: a T1 relaxation time study.

  2006cited by this paper
• Significance of T2 lesions in multiple sclerosis: A 13‐year longitudinal study

  2006cited by this paper
• BMC Neurology BioMed Central

  2006cited by this paper
• Pulsed magnetization transfer imaging with body coil transmission at 3 Tesla: Feasibility and application

  2006cited by this paper
• Diffusion tensor imaging in multiple sclerosis: assessment of regional differences in the axial plane within normal-appearing cervical spinal cord.

  2006cited by this paper
• Spinal Cord Gray Matter Demyelination in Multiple Sclerosis—A Novel Pattern of Residual Plaque Morphology

  2006influential reference
• Imaging of inflammatory lesions at 3.0 Tesla in patients with clinically isolated syndromes suggestive of multiple sclerosis: a comparison of fluid-attenuated inversion recovery with T2 turbo spin-echo

  2006cited by this paper
• Cognitive impairment is associated with subcortical magnetic resonance imaging grey matter T2 hypointensity in multiple sclerosis

  2006cited by this paper
• A Magnetization Transfer MRI Study of Deep Gray Matter Involvement in Multiple Sclerosis

  2006influential reference
• Magnetic resonance imaging measures of brain atrophy in multiple sclerosis

  2006cited by this paper
• Accurate quantification methods to evaluate cervical cord atrophy in multiple sclerosis patients

  2006cited by this paper
• Higher sensitivity in the detection of inflammatory brain lesions in patients with clinically isolated syndromes suggestive of multiple sclerosis using high field MRI: an intraindividual comparison of 1.5 T with 3.0 T

  2006cited by this paper
• Magnetic Resonance Imaging of Iron Deposition in Neurological Disorders

  2006cited by this paper
• Correlation of global N-acetyl aspartate with cognitive impairment in multiple sclerosis.

  2006cited by this paper
• Standardized MR imaging protocol for multiple sclerosis: Consortium of MS Centers consensus guidelines.

  2006cited by this paper
• Does high-field MR imaging have an influence on the classification of patients with clinically isolated syndromes according to current diagnostic mr imaging criteria for multiple sclerosis?

  2006influential reference
• MR imaging of relapsing multiple sclerosis patients using ultra-small-particle iron oxide and compared with gadolinium.

  2006cited by this paper
• Magnetization transfer MRI metrics predict the accumulation of disability 8 years later in patients with multiple sclerosis.

  2006cited by this paper
• Magnetization transfer magnetic resonance imaging and clinical changes in patients with relapsing-remitting multiple sclerosis.

  2006cited by this paper
• Normal-appearing white matter changes vary with distance to lesions in multiple sclerosis.

  2006influential reference
• Myelin water imaging in multiple sclerosis: quantitative correlations with histopathology

  2006cited by this paper
• The measurement and clinical relevance of brain atrophy in multiple sclerosis.

  2006influential reference
• Semi-automatic brain region extraction (SABRE) reveals superior cortical and deep gray matter atrophy in MS

  2006cited by this paper
• Segmentation and quantification of black holes in multiple sclerosis

  2006cited by this paper
• Voxel-based analysis of quantitative T1 maps demonstrates that multiple sclerosis acts throughout the normal-appearing white matter.

  2006cited by this paper
• FLAIR imaging for multiple sclerosis: a comparative MR study at 1.5 and 3.0 Tesla

  2006cited by this paper
• Brain damage as detected by magnetization transfer imaging is less pronounced in benign than in early relapsing multiple sclerosis.

  2006cited by this paper
• MRI T2 lesion burden in multiple sclerosis

  2006cited by this paper
• Whole-brain T1 mapping in multiple sclerosis: global changes of normal-appearing gray and white matter.

  2006cited by this paper
• Brain atrophy after immunoablation and stem cell transplantation in multiple sclerosis

  2006cited by this paper
• Functional Magnetic Resonance Imaging and Multiple Sclerosis: The Evidence for Neuronal Plasticity

  2005cited by this paper
• The relationship between whole brain volume and disability in multiple sclerosis: A comparison of normalized gray vs. white matter with misclassification correction

  2005influential reference
• Evidence for progressive gray matter loss in patients with relapsing-remitting MS

  2005cited by this paper
• Magnetization Transfer Imaging in Multiple Sclerosis

  2005cited by this paper
• Local tissue damage assessed with statistical mapping analysis of brain magnetization transfer ratio: relationship with functional status of patients in the earliest stage of multiple sclerosis.

  2005cited by this paper
• MRI T2 hypointensity of the dentate nucleus is related to ambulatory impairment in multiple sclerosis.

  2005cited by this paper
• Abnormalities in normal appearing tissues in early primary progressive multiple sclerosis and their relation to disability: a tissue specific magnetisation transfer study

  2005cited by this paper
• Intracortical lesions in multiple sclerosis: improved detection with 3D double inversion-recovery MR imaging.

  2005cited by this paper
• Metabolite changes in normal-appearing gray and white matter are linked with disability in early primary progressive multiple sclerosis.

  2005cited by this paper
• Imaging of multiple sclerosis: Role in neurotherapeutics

  2005influential reference
• Magnetic Resonance Spectroscopy in the Monitoring of Multiple Sclerosis

  2005cited by this paper
• Quantification of magnetization transfer rate and native T1 relaxation time of the brain: correlation with magnetization transfer ratio measurements in patients with multiple sclerosis

  2005cited by this paper
• Spinal Cord Imaging in Multiple Sclerosis

  2005cited by this paper
• Safety of Serial Monthly Administration of Triple‐Dose Gadopentetate Dimeglumine in Multiple Sclerosis Patients: Preliminary Results of the BECOME Trial

  2005cited by this paper
• Measurement of Brain and Spinal Cord Atrophy by Magnetic Resonance Imaging as a Tool to Monitor Multiple Sclerosis

  2005cited by this paper
• Short-term accrual of gray matter pathology in patients with progressive multiple sclerosis: an in vivo study using diffusion tensor MRI

  2005cited by this paper
• Prediction of longitudinal brain atrophy in multiple sclerosis by gray matter magnetic resonance imaging T2 hypointensity.

  2005cited by this paper
• Patterns of enhancing lesion evolution in multiple sclerosis are uniform within patients

  2005cited by this paper
• Brain atrophy and magnetization transfer ratio following methylprednisolone in multiple sclerosis: short-term changes and long-term implications

  2005cited by this paper
• Magnetization transfer histograms in clinically isolated syndromes suggestive of multiple sclerosis.

  2005cited by this paper
• Emergence of thalamic magnetization transfer ratio abnormality in early relapsing—remitting multiple sclerosis

  2005cited by this paper
• Evidence of elevated glutamate in multiple sclerosis using magnetic resonance spectroscopy at 3 T.

  2005cited by this paper
• Diffusion Tensor Magnetic Resonance Imaging in Multiple Sclerosis

  2005cited by this paper

• Conventional and Advanced Magnetic Resonance Imaging Biomarkers of Multiple Sclerosis in the Brain

  2025influential citation
• Hematological Factors and MRI in Covid-19 Infected may Predict the Prevalence of Multiple Sclerosis in the Post-Covid era

  2024cites this paper
• The Value of Various Post-Processing Modalities of Diffusion Weighted Imaging in the Detection of Multiple Sclerosis

  2023cites this paper
• Evolution of acute “black hole” lesions in patients with relapsing–remitting multiple sclerosis

  2022cites this paper
• Immunopathogenesis, Diagnosis, and Treatment of Multiple Sclerosis: A Clinical Update.

  2022cites this paper
• A brief review of non-invasive brain imaging technologies and the near-infrared optical bioimaging

  2021cites this paper
• Widespread Disruptions of White Matter in Familial Multiple Sclerosis: DTI and NODDI Study

  2021cites this paper
• Degree of microstructural changes within T1-SE versus T1-GE hypointense lesions in multiple sclerosis: relevance for the definition of “black holes”

  2020cites this paper
• Multiple Sclerosis multimodal lesion simulation tool (MS-MIST)

  2019cites this paper
• Microstructural imaging in the spinal cord and validation strategies

  2018cites this paper
• Magnetic Resonance Imaging in Multiple Sclerosis.

  2018influential citation
• Treatment of multiple sclerosis relapses with high-dose methylprednisolone reduces the evolution of contrast-enhancing lesions into persistent black holes

  2018cites this paper
• A Novel Classification Method using Effective Neural Network and Quantitative Magnetization Transfer Imaging of Brain White Matter in Relapsing Remitting Multiple Sclerosis

  2018cites this paper
• Whole‐brain atrophy assessed by proportional‐ versus registration‐based pipelines from 3T MRI in multiple sclerosis

  2018cites this paper
• A hybrid approach based on logistic classification and iterative contrast enhancement algorithm for hyperintense multiple sclerosis lesion segmentation

  2017cites this paper
• Turning White Matter “Inside-Out” by Hyper-deimination of Myelin Basic Protein (MBP)

  2017cites this paper
• Evaluation of multiple sclerosis patients through structural biomarkers of diffusion tensor magnetic imaging and correlation with clinical features

  2016cites this paper
• Dilated perivascular spaces and fatigue: is there a link? Magnetic resonance retrospective 3Tesla study

  2016cites this paper
• Neuroradiological aspects of Multiple Sclerosis : from early signs to late disease stages

  2015cites this paper
• Body fluid biomarkers in multiple sclerosis: how far we have come and how they could affect the clinic now and in the future

  2015cites this paper
• Normalization of White Matter Intensity on T1‐Weighted Images of Patients with Acquired Central Nervous System Demyelination

  2015cites this paper
• MRI detection of hypointense brain lesions in patients with multiple sclerosis: T1 spin-echo vs. gradient-echo.

  2015cites this paper
• Multi-exponential T2 Myelin Water Imaging in Ex-Vivo Rodent Brain at 7T and 15.2T

  2014influential citation
• Analysis of single nucleotide polymorphisms with opposite effects on serum iron parameters in South African patients with multiple sclerosis

  2014cites this paper
• White matter abnormalities: Insights into the pathophysiology of major affective disorders.

  2014cites this paper
• Microwave & Magnetic (M2) Proteomics Reveals CNS-Specific Protein Expression Waves that Precede Clinical Symptoms of Experimental Autoimmune Encephalomyelitis

  2014cites this paper
• Recovery of locomotion after partial spinal cord lesions in cats: assessment using behavioral, electrophysiological and imaging techniques.

  2014cites this paper
• ANALYSIS OF MULTIPLE SCLEROSIS LESIONS VIA SPATIALLY VARYING COEFFICIENTS.

  2014cites this paper
• Elucidating Disease Modifying Roles of Radio-resistant, CNS Resident Cells in a Rodent Model of Multiple Sclerosis

  2014influential citation
• Paramètres cliniques, biochimiques et dimagerie prédictifs de I évolution de la sclérose en plaques

  2013cites this paper
• Myalgic encephalomyelitis/chronic fatigue syndrome and encephalomyelitis disseminata/multiple sclerosis show remarkable levels of similarity in phenomenology and neuroimmune characteristics

  2013cites this paper
• Fully automatic detection of deep white matter T1 hypointense lesions in multiple sclerosis

  2013influential citation
• Brain and Cranial Nerve Disorders

  2013cites this paper
• Tissue similarity maps (TSMs): a new means of mapping vascular behavior and calculating relative blood volume in perfusion weighted imaging.

  2013cites this paper
• A Biomaterials Approach for an Ex-Vivo Multiple Sclerosis Model of Inflammatory Demyelination

  2013cites this paper
• Fast dimension-reduced climate model calibration and the effect of data aggregation

  2013cites this paper
• Nuclear Potential Clustering As a New Tool to Detect Patterns in High Dimensional Datasets

  2013cites this paper
• Correlation of Diffusion and Metabolic Alterations in Different Clinical Forms of Multiple Sclerosis

  2012cites this paper
• Study of Myelin Sheaths by Cars Microscopy

  2012cites this paper
• Rapid myelin water content mapping on clinical MR systems.

  2012cites this paper
• Corpus Callosum Atrophy – A Simple Predictor of Multiple Sclerosis Progression: A Longitudinal 9-Year Study

  2012cites this paper
• Cervical spinal cord injection of epidural corticosteroids: Comprehensive longitudinal study including multiparametric magnetic resonance imaging

  2012cites this paper
• Adherence to MRI protocol consensus guidelines in multiple sclerosis: An Australian multi‐centre study

  2012cites this paper
• Quantification of Perfusion and Permeability in Multiple Sclerosis: Dynamic Contrast-Enhanced MRI in 3D at 3T

  2012cites this paper
• Characterizing contrast-enhancing and re-enhancing lesions in multiple sclerosis

  2012cites this paper
• Improving the clinical correlation of multiple sclerosis black hole volume change by paired-scan analysis☆

  2012influential citation
• Spatial dispersion of lesions as a surrogate biomarker for disability in multiple sclerosis

  2012cites this paper
• Magnetic resonance disease severity scale (MRDSS) for patients with multiple sclerosis: a longitudinal study.

  2012cites this paper
• Magnetic resonance imaging in multiple sclerosis.

  2012cites this paper
• Parámetros cuantitativos de la resonancia magnética cerebral en esclerosis múltiple y su correlación con la discapacidad

  2011influential citation
• Remyelination in Multiple Sclerosis

  2011cites this paper
• Reassessment of Blood Gene Expression Markers for the Prognosis of Relapsing-Remitting Multiple Sclerosis

  2011cites this paper
• The impact of intensity variations in T1-hypointense lesions on clinical correlations in multiple sclerosis

  2011cites this paper
• In vivo evidence of disseminated subpial T2* signal changes in multiple sclerosis at 7 T: A surface-based analysis

  2011cites this paper
• ole of MRI in diagnosis and treatment of multiple sclerosis ohammad

  2010cites this paper
• Successful treatment of central pain in a multiple sclerosis patient with epidural stimulation of the dorsal root entry zone.

  2010cites this paper
• An optimised framework for reconstructing and processing MR phase images

  2010cites this paper
• Cerebral restorative plasticity from normal ageing to brain diseases: A "never ending story"

  2010cites this paper
• Role of MRI in diagnosis and treatment of multiple sclerosis.

  2010cites this paper
• Brain metabolite proton T2 mapping at 3.0 T in relapsing-remitting multiple sclerosis.

  2010cites this paper
• Composite MRI scores improve correlation with EDSS in multiple sclerosis

  2010cites this paper
• Imaging of active multiple sclerosis plaques: efficiency of contrast-enhanced magnetization transfer subtraction technique.

  2010cites this paper
• BRAIN VOLUME REDUCTION OVER FOUR DECADES IN MULTIPLE SCLEROSIS

  2010cites this paper
• Recent Developments in the Early Diagnosis and Management of Multiple Sclerosis

  2010influential citation
• Towards a unifying, systems biology understanding of large-scale cellular death and destruction caused by poorly liganded iron: Parkinson’s, Huntington’s, Alzheimer’s, prions, bactericides, chemical toxicology and others as examples

  2010cites this paper
• Rapid Simultaneous Mapping of Total and Myelin Water Content, T1 and T2* in Multiple Sclerosis

  2010cites this paper
• Advanced magnetic resonance imaging techniques to better understand multiple sclerosis

  2010cites this paper
• Advanced Experimental Magnetic Resonance Imaging

  2009cites this paper
• Table of Contents Current and Future Directions in MS Management : Key Considerations for Managed Care Pharmacists

  2009cites this paper
• Deep Gray Matter Involvement on Brain MRI Scans Is Associated with Clinical Progression in Multiple Sclerosis

  2009cites this paper
• Imaging patterns of inflammation in multiple sclerosis: a multifocal approach

  2009cites this paper
• Current and Future Directions in MS Management: Key Considerations for Managed Care Pharmacists

  2009cites this paper
• Anatomo-functional magnetic resonance imaging of the spinal cord and its application to the characterization of spinal lesions in cats

  2009cites this paper
• Enhancing the ability of experimental autoimmune encephalomyelitis to serve as a more rigorous model of multiple sclerosis through refinement of the experimental design.

  2009cites this paper
• Spinal cord lesions and clinical status in multiple sclerosis: A 1.5 T and 3 T MRI study.

  2009cites this paper
• Review of the Clinical Debate Regarding Interventions for Multiple Sclerosis

  2009cites this paper
• Susceptibility contrast in high field MRI of human brain as a function of tissue iron content

  2009cites this paper
• 3 T MRI relaxometry detects T2 prolongation in the cerebral normal-appearing white matter in multiple sclerosis

  2009cites this paper
• MR spectroscopy (MRS) and magnetisation transfer imaging (MTI), lesion load and clinical scores in early relapsing remitting multiple sclerosis: a combined cross-sectional and longitudinal study

  2009cites this paper
• Normal Findings on Brain Fluid-Attenuated Inversion Recovery MR Images at 3T

  2009cites this paper
• Reproducibility of tract‐specific magnetization transfer and diffusion tensor imaging in the cervical spinal cord at 3 tesla

  2009cites this paper
• The Treatment of Multiple Sclerosis with Inosine

  2009cites this paper
• The diagnosis of MS

  2008cites this paper
• MRI in multiple sclerosis: current status and future prospects.

  2008cites this paper
• From fish to man: understanding endogenous remyelination in central nervous system demyelinating diseases

  2008cites this paper